C. militaris is one of the important medicinal species and well documented for its anticancer effects.
C. militaris ethanolic extract was orally administered to a xenograft in mice bearing murine T cell lymphoma (RMA) cell-derived cancers, which resulted in significant anticancer activity by the suppressing the size and mass of cancer. Furthermore, reduced proliferation of RMA cells and C6 glioma cells, downregulation of phosphorylation of AKT, p85 and augmented cleaved caspase-3, phosphoglycogen synthase kinase 3β (p-GSK3β) were reported. The extract significantly increased the proapoptotic cell population and reduced viability compared to control cells. The finding indicates the anticancerous activity of
C. militaris occurred by regulating of p85/AKT- or GSK3β-related caspase 3-dependent apoptosis
[11]. Similarly, methanolic extracts showed good cytotoxic activity via the MTT assay against Hep-2 cancer cell lines with an IC
50 value of 20 μg/mL
[12]. In another study, the effect of fluoride was monitored in the culture medium of
C. militaris, and positive effects were observed on the synthesis of secondary bioactive metabolites and growth of fruiting bodies, which eventually caused reduced proliferation and apoptosis in a human osteosarcoma (U2OS) cell line
[13]. Another study discussed the decreased apoptotic activity of aqueous extract of
C. militaris (AECM) on MDA-MB-231 cells. It showed significant induction of mitochondrial dysfunction and loss of mitochondrial membrane permeability by modulating Bcl2/Bax proteins, and also caspase activation
[14]. Another report showed the tumor inhibitory effects of an ethanolic extract of
C. militaris in xenograft Balb/c nude mice transfected with human colorectal carcinoma RKO cells. The oral administration of test extracts led to delayed growth of RKO cell-derived tumors. It also stimulated cell cycle arrest in G2/M phase (66.33% at 300 μg/mL) and enhanced early apoptosis (18.07% at 300 μg/mL). Western blot analysis indicated an increase in the expression levels of p53, cleaved caspase 9, cleaved caspase-3, cleaved PARP, and Bim, Bak, and Bad proteins
[15]. A mechanistic based study conducted by Chou et al., revealed that anticancerous effects of
C. militaris on leukemia cell lines might be attributed to activation of AKT and p38 mitogen activated protein kinase (MAPK), during the course of apoptosis induction, suggesting the possible use of its extracts against leukemia by activating the p38 MAPK pathway
[16]. Another mechanism of the apoptosis of lung carcinoma by
C. militaris extracts is related to downregulation of TCTN3 expression, which affected the hedgehog signaling cascade and contributed to the serial activation of caspases. Additionally, the extract negatively modulated GLI1 transcriptional activity by inhibiting SMO/PTCH1 molecules, subsequently regulating the intrinsic apoptotic signaling cascade
[17]. All these findings support the possible use of
C. militaris extracts as anticancer agents in future studies.